InsiderTrades

Form 4 for MCD McDonald's

Accepted 2026-02-17 00:00:00 ET · period of report 2026-02-13 · accession 0001685800-26-000001 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-02-17 2026-02-13 MCD Erlinger Joseph M. Pres, McDonald's USA F - Tax $327.58 -2,312 9,066 -20% -$757.4K
DM 2026-02-17 2026-02-13 MCD Erlinger Joseph M. Pres, McDonald's USA M - OptEx $0.00 +5,980 11.4K +111% $0
DM 2026-02-17 2026-02-13 MCD Erlinger Joseph M. Pres, McDonald's USA M - OptEx $0.00 -5,980 0 -100% $0
D 2026-02-17 2026-02-13 MCD Erlinger Joseph M. Pres, McDonald's USA A - Grant $0.00 +32.1K 32.1K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-02-13 F D 2,312.23 $327.58 9,065.89 D — —
2 Common Common Stock 2026-02-13 M A 5,577 $0.00 10,975.12 D — — (F1) As a result of McDonald's Corporation's (the "Company") performance against the pre-approved financial targets for the performance period of January 1, 2023 through December 31, 2025, the reporting person vested in 82.2% of the original grant of 6,785 performance-based restricted stock units ("RSUs"). (F2) Each performance-based RSU represents a right to acquire one share of the Company's common stock.
3 Common Common Stock 2026-02-13 M A 403 $0.00 11,378.12 D — — (F3) Settlement of dividend equivalent rights in connection with vested RSUs. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock.
4 Derivative Restricted Stock Units 2026-02-13 M D 5,577 $0.00 0 D — · 2026-02-13 to 2026-02-13 5,577 Common Stock (F1) As a result of McDonald's Corporation's (the "Company") performance against the pre-approved financial targets for the performance period of January 1, 2023 through December 31, 2025, the reporting person vested in 82.2% of the original grant of 6,785 performance-based restricted stock units ("RSUs"). (F2) Each performance-based RSU represents a right to acquire one share of the Company's common stock.
5 Derivative Options (Right to Buy) 2026-02-13 A A 32,093 $0.00 32,093 D $327.58 · — to 2036-02-13 32,093 Common Stock (F4) Options become exercisable in 25% increments on the first, second, third and fourth anniversary dates of the grant.
6 Derivative Dividend Equilavent Rights 2026-02-13 M D 403 $0.00 0 D — · 2026-02-13 to 2026-02-13 403 Common Stock (F3) Settlement of dividend equivalent rights in connection with vested RSUs. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock.